A Food Effect Phase I Study of the Clifutinib in Healthy Subjects
Latest Information Update: 23 Mar 2023
At a glance
- Drugs Clifutinib besylate (Primary)
- Indications Acute myeloid leukaemia
- Focus Pharmacokinetics
- Sponsors Sunshine Lake Pharma
Most Recent Events
- 20 Mar 2023 Status changed from not yet recruiting to completed.
- 25 Oct 2022 Planned initiation date changed from 30 Aug 2022 to 30 Nov 2022.
- 14 Jul 2022 New trial record